vs

Side-by-side financial comparison of GCT Semiconductor Holding, Inc. (GCTS) and Arcadia Biosciences, Inc. (RKDA). Click either name above to swap in a different company.

Arcadia Biosciences, Inc. is the larger business by last-quarter revenue ($901.0K vs $758.0K, roughly 1.2× GCT Semiconductor Holding, Inc.). Arcadia Biosciences, Inc. runs the higher net margin — -148.3% vs -1189.6%, a 1041.3% gap on every dollar of revenue. On growth, Arcadia Biosciences, Inc. posted the faster year-over-year revenue change (-25.8% vs -57.5%). Over the past eight quarters, Arcadia Biosciences, Inc.'s revenue compounded faster (-4.5% CAGR vs -58.8%).

GCT Semiconductor Holding, Inc. designs, develops and supplies high-performance wireless semiconductor solutions. Its product portfolio includes 4G LTE, 5G and IoT connectivity chips tailored for consumer electronics, industrial devices and telecom equipment. The company serves customers across North America, Asia-Pacific and European markets, with core segments covering mobile communications and edge connected devices.

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.

GCTS vs RKDA — Head-to-Head

Bigger by revenue
RKDA
RKDA
1.2× larger
RKDA
$901.0K
$758.0K
GCTS
Growing faster (revenue YoY)
RKDA
RKDA
+31.7% gap
RKDA
-25.8%
-57.5%
GCTS
Higher net margin
RKDA
RKDA
1041.3% more per $
RKDA
-148.3%
-1189.6%
GCTS
Faster 2-yr revenue CAGR
RKDA
RKDA
Annualised
RKDA
-4.5%
-58.8%
GCTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GCTS
GCTS
RKDA
RKDA
Revenue
$758.0K
$901.0K
Net Profit
$-9.0M
$-1.3M
Gross Margin
-162.7%
21.4%
Operating Margin
-1577.0%
-152.8%
Net Margin
-1189.6%
-148.3%
Revenue YoY
-57.5%
-25.8%
Net Profit YoY
-81.4%
67.1%
EPS (diluted)
$-0.16
$-0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCTS
GCTS
RKDA
RKDA
Q4 25
$758.0K
$901.0K
Q3 25
$1.3M
Q2 25
$1.2M
$1.5M
Q1 25
$1.2M
Q4 24
$1.8M
$1.2M
Q3 24
$2.6M
$1.5M
Q2 24
$1.5M
$1.3M
Q1 24
$3.3M
$987.0K
Net Profit
GCTS
GCTS
RKDA
RKDA
Q4 25
$-9.0M
$-1.3M
Q3 25
$856.0K
Q2 25
$-13.5M
$-4.5M
Q1 25
$2.6M
Q4 24
$-5.0M
$-4.1M
Q3 24
$-7.1M
$-1.6M
Q2 24
$-1.0M
$1.1M
Q1 24
$757.0K
$-2.4M
Gross Margin
GCTS
GCTS
RKDA
RKDA
Q4 25
-162.7%
21.4%
Q3 25
32.1%
Q2 25
32.0%
43.4%
Q1 25
43.2%
Q4 24
32.3%
31.9%
Q3 24
62.3%
32.9%
Q2 24
62.7%
51.5%
Q1 24
59.8%
52.3%
Operating Margin
GCTS
GCTS
RKDA
RKDA
Q4 25
-1577.0%
-152.8%
Q3 25
-88.5%
Q2 25
-642.3%
-34.4%
Q1 25
44.2%
Q4 24
-412.7%
-187.7%
Q3 24
-226.5%
-114.5%
Q2 24
-482.2%
Q1 24
-160.9%
Net Margin
GCTS
GCTS
RKDA
RKDA
Q4 25
-1189.6%
-148.3%
Q3 25
65.7%
Q2 25
-1145.3%
-306.4%
Q1 25
216.6%
Q4 24
-278.5%
-334.5%
Q3 24
-272.8%
-104.9%
Q2 24
-71.0%
81.2%
Q1 24
23.2%
-245.5%
EPS (diluted)
GCTS
GCTS
RKDA
RKDA
Q4 25
$-0.16
$-0.97
Q3 25
$0.62
Q2 25
$-0.26
$-3.26
Q1 25
$1.90
Q4 24
$-0.15
$-2.99
Q3 24
$-0.16
$-1.18
Q2 24
$-0.02
$0.78
Q1 24
$0.03
$-1.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCTS
GCTS
RKDA
RKDA
Cash + ST InvestmentsLiquidity on hand
$590.0K
$4.6M
Total DebtLower is stronger
$62.6M
Stockholders' EquityBook value
$-83.3M
$4.1M
Total Assets
$15.6M
$6.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCTS
GCTS
RKDA
RKDA
Q4 25
$590.0K
$4.6M
Q3 25
$5.9M
Q2 25
$1.3M
$4.4M
Q1 25
$3.2M
Q4 24
$1.4M
$4.2M
Q3 24
$1.8M
$6.6M
Q2 24
$4.0M
$8.1M
Q1 24
$16.1M
$8.5M
Total Debt
GCTS
GCTS
RKDA
RKDA
Q4 25
$62.6M
Q3 25
Q2 25
$51.7M
Q1 25
Q4 24
$42.6M
Q3 24
$41.8M
Q2 24
$43.6M
Q1 24
$50.5M
Stockholders' Equity
GCTS
GCTS
RKDA
RKDA
Q4 25
$-83.3M
$4.1M
Q3 25
$5.4M
Q2 25
$-70.0M
$4.5M
Q1 25
$8.9M
Q4 24
$-59.3M
$6.2M
Q3 24
$-58.3M
$10.3M
Q2 24
$-58.3M
$11.7M
Q1 24
$-62.4M
$10.6M
Total Assets
GCTS
GCTS
RKDA
RKDA
Q4 25
$15.6M
$6.5M
Q3 25
$8.6M
Q2 25
$17.6M
$7.8M
Q1 25
$13.0M
Q4 24
$19.9M
$13.5M
Q3 24
$22.6M
$15.2M
Q2 24
$23.4M
$17.4M
Q1 24
$35.8M
$16.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCTS
GCTS
RKDA
RKDA
Operating Cash FlowLast quarter
$-7.2M
$-861.0K
Free Cash FlowOCF − Capex
$-8.5M
FCF MarginFCF / Revenue
-1120.2%
Capex IntensityCapex / Revenue
167.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCTS
GCTS
RKDA
RKDA
Q4 25
$-7.2M
$-861.0K
Q3 25
$-257.0K
Q2 25
$-8.6M
$-2.0M
Q1 25
$-1.6M
Q4 24
$-2.3M
$-2.2M
Q3 24
$-4.6M
$-1.8M
Q2 24
$-9.6M
$-2.5M
Q1 24
$-14.4M
$-3.2M
Free Cash Flow
GCTS
GCTS
RKDA
RKDA
Q4 25
$-8.5M
Q3 25
Q2 25
$-8.7M
Q1 25
Q4 24
Q3 24
$-4.7M
Q2 24
$-2.5M
Q1 24
$-3.2M
FCF Margin
GCTS
GCTS
RKDA
RKDA
Q4 25
-1120.2%
Q3 25
Q2 25
-738.5%
Q1 25
Q4 24
Q3 24
-179.3%
Q2 24
-188.3%
Q1 24
-326.5%
Capex Intensity
GCTS
GCTS
RKDA
RKDA
Q4 25
167.3%
0.0%
Q3 25
0.0%
Q2 25
7.7%
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
2.1%
0.0%
Q2 24
0.2%
Q1 24
1.3%
Cash Conversion
GCTS
GCTS
RKDA
RKDA
Q4 25
Q3 25
-0.30×
Q2 25
Q1 25
-0.61×
Q4 24
Q3 24
Q2 24
-2.31×
Q1 24
-19.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons